Aerox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aerox

Quick Facts

Property Description
Active Ingredient Simethicone (Activated Polydimethylsiloxane)
Form Oral (Suspension, Chewable Tablet, Capsule)
Pharmacological Class Gastrointestinal Agent, Antiflatulent
Common Use Relief of gas, bloating, and abdominal discomfort
Origin Synthetic (Silicone-based compound)

Aerox: Classification and Active Ingredient

Aerox is classified as a gastrointestinal agent belonging to the antiflatulent pharmacological class, distinguished by its physical mechanism of action. The active ingredient in Aerox is Simethicone, a synthetic silicone-based compound known chemically as activated polydimethylpolysiloxane.

Simethicone is a recognized single-component product (monodrug) that functions as a non-systemic agent, meaning it is minimally absorbed into the bloodstream. Simethicone is widely recognized as an effective over-the-counter treatment for reducing flatulence and gas-related functional abdominal pain. This established efficacy profile supports its use across broad patient groups, from infants to adults.


What are the Available Forms and General Purpose?

Aerox is an orally administered medicine available in several dosage forms, notably a suspension (oral drops), which is a differentiating factor often prioritized for infants and young children, alongside chewable tablets and capsules for adult use. The general purpose of this medicine is to provide relief from the physical discomfort and sensation of fullness associated with excessive gas, bloating, and flatulence.

Simethicone achieves this by acting as a surface-active agent that executes a defoaming action within the digestive tract. It reduces the surface tension of small, trapped gas bubbles, promoting their coalescence into larger, more manageable gas pockets. Simethicone has an established use for managing gastrointestinal gas symptoms in adults and children. This unique physical property also makes it a valuable aid for clearing the field of view during specific diagnostic procedures, such as medical imaging of the gastrointestinal tract.

Regulatory References

  1. National Institutes of Health (NIH)

What side effects are possible with Aerox?

Possible Side Effects and Safety Information

The safety profile of Aerox (Simethicone) is shaped by its mechanism of action as a non-systemic agent, meaning it is minimally or negligibly absorbed into the bloodstream. Consequently, documented adverse reactions are primarily localized to the digestive tract and are generally limited.

Officially documented adverse reactions are primarily classified within the Gastro-Intestinal Disorders and the Immune System Disorders system-organ classes.


Officially Documented Adverse Reactions

Adverse reactions associated with Simethicone are often categorized by frequency in regulatory documents. Gastrointestinal complaints such as nausea, vomiting, constipation, or loose stools have been reported in post-marketing data, with some classified as Uncommon or of Not Known frequency (meaning they cannot be estimated reliably from available data).

The most clinically significant safety event documented involves the Immune System Disorders class: rare Hypersensitivity reactions. These are considered serious adverse reactions and may include symptoms such as rash, pruritus (itching), face oedema, tongue oedema, and associated respiratory difficulty.


Safety Considerations and Restrictions

The medicine is formally contraindicated for individuals with a known hypersensitivity or allergy to Simethicone or any of the product’s components. This constitutes the main safety restriction.

Due to the negligible systemic absorption, regulatory statements indicate no specific effects are anticipated during pregnancy or on the breastfed newborn/infant. Safety data for pediatric use also generally shows no different side effects or problems than in adults. Furthermore, the product may interfere with certain diagnostic procedures, specifically causing false-negative results in the Gastric Guaiac Test.

Overdose and Emergency Response

Overdose and When to Seek Help

Aerox, which contains Simethicone, has a unique overdose profile due to its non-systemic nature. Regulatory documents confirm that the active ingredient is pharmacologically inert and not absorbed from the gastrointestinal tract, making systemic toxic effects unlikely.

Documented Manifestations and Actions

Domain Official Regulatory Statement
Overdose Manifestations No case of overdose has been reported in regulatory summaries. Theoretically, constipation may occur following the ingestion of extremely high doses.
Immediate Action Required The labeling strictly mandates users to seek medical help or contact a Poison Control Center right away if too much is used. In urgent situations, the instruction is to Call 911 (or local emergency services).
Antidote Information No specific antidote is known or documented due to the compound's non-absorbed nature.
Supportive Management Management is restricted to symptomatic and supportive treatment, including instructions to treat with fluids and keep under observation if theoretical effects develop.

This structure reflects the low systemic risk but emphasizes regulator-mandated protocols for professional assessment. Population-specific overdose considerations are not explicitly detailed in the official overdose sections.

Therapeutic Uses of Aerox

What Aerox Treats: Main Uses and Benefits

Aerox is used to provide symptomatic relief for the distress caused by excess air and gas trapped in the digestive tract. Simethicone is used to manage symptoms such as uncomfortable or painful pressure, fullness, and bloating, which supports general well-being during symptomatic periods.


Targeting Discomfort and Functional Strain

The medication is relevant for easing primary symptom groups, including abdominal distension and fullness, and helping with the painful cramping associated with gas entrapment. It is commonly used across conditions characterized by periods of heightened symptoms, such as in cases of functional abdominal pain, or for supportive management of certain Irritable Bowel Syndrome (IBS) manifestations. It also applies to clinical scenarios like managing postoperative gas pain and providing relief for gas-related discomfort in infants and children. In essence:

“The medication is primarily relevant for easing symptoms that interfere with daily comfort.”

Aerox is applied in contexts where symptoms lead to temporary functional strain, providing assistance in managing episodes of acute gas pain and addressing the recurrence of uncomfortable bloating. This symptomatic assistance is appropriate for domains where short-term supportive relief is needed, may help patients cope more steadily with symptom fluctuations, and contributes to easing the overall symptom load.

Quick Fact: Managing Trapped Gas Symptoms
Main Uses Assists with symptomatic relief of gas, bloating, and abdominal pressure.
Common Patient Groups Adults, children, and infants experiencing gas distress.
Key Benefit Contributes to improved comfort and assists with easing the overall symptom load.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Aerox?

This section outlines the official population eligibility and exclusion criteria for Aerox (Cefuroxime Axetil) as documented in government regulatory sources, strictly according to label information.


Populations that Must Not Use Aerox (Contraindications)

Classification Population/Condition
Absolute Contraindication Individuals with a documented history of hypersensitivity (allergic reaction) to Cefuroxime, other drugs in the cephalosporin class, or penicillin antibiotics.
Dosage Form Restriction Patients with Phenylketonuria (PKU) must not use the oral suspension due to the presence of phenylalanine (from aspartame).

Restricted or Conditional Use Populations

Classification Population/Condition
Special Consideration Patients with a history of gastrointestinal disease, particularly colitis, or pre-existing kidney or liver disease.
Drug-Interaction Consideration Females using hormonal contraceptives should be advised that the medication may decrease the contraceptive's effectiveness, necessitating the use of an alternative birth control method.

Age-Related Eligibility: Pediatric use is established, but the suspension form presents a compliance issue for young children if tablets need to be crushed.

Pregnancy and Lactation: Use is generally permitted, but specific safety data and risk assessment should be discussed with a healthcare provider.

What should I know about interactions with other medicines?

Aerox Interactions with other medicines and products

Drug-Drug Interactions (Official Documentation)

The regulatory interaction profile of Aerox (Simethicone) is defined by its classification as a non-systemic agent. As the active ingredient is minimally absorbed, official documents do not typically list interactions involving metabolic (CYP-enzyme) or systemic transporter-mediated pathways. No medicinal product is formally listed as contraindicated for co-administration due to interaction risk in the official prescribing information.

Exposure-Modifying Substances

The interaction potential is structurally confined to physical absorption interference in the gastrointestinal tract. Regulatory-aligned literature cites specific interactions where co-administration modifies the exposure of other oral agents:

  • Levothyroxine: Co-administration is documented to result in reduced systemic exposure of Levothyroxine.
  • Carbamazepine: Co-administration has been associated with increased plasma levels of Carbamazepine.

Contextual Constraints

Official government drug labels do not list specific restrictions or cautions concerning concurrent use with food, alcohol, or herbal products. Additionally, mandatory time-separation requirements for administration are not specified in the product labeling. The official interaction structure is consistently defined by the product's physical action and lack of systemic involvement.

Mechanism of Action

Aerox (Simethicone) operates via a unique, non-systemic approach that is entirely physical rather than pharmacological, meaning it does not bind to biological receptors or enzymes. Its mechanism is focused solely on modulating gas dynamics within the gastrointestinal lumen.

Reducing Intraluminal Surface Tension

The mechanism initiates as the active ingredient acts as a surface-active agent (surfactant), locally reducing the surface tension of small gas bubbles suspended in the gut contents. This interaction destabilizes the physical integrity of the foam, altering the physical state of the gas. This mechanistic domain supports the conditions for bulk gas expulsion.

Facilitating Gas Coalescence and Pressure Modulation

The immediate physiological consequence of the reduced surface tension is the rapid coalescence of small bubbles into fewer, larger pockets of gas. This conversion from foam to bulk gas modulates intraluminal pressure by facilitating gas expulsion through natural means. This entirely local action determines the resulting physiological change without requiring systemic absorption.

Dosage and Administration Information

How to Use Aerox: Official Administration Guidelines

Aerox (Simethicone) is an oral-use gastrointestinal agent administered consistent with established guidelines to address symptomatic needs. The entire administration protocol is defined by specific dosage limits, frequency patterns, and rules for preparation and ingestion, as outlined in prescribing information.


Administration Scope

The approved route of administration for Aerox is oral. Use is generally scheduled after meals and at bedtime to align with periods of likely gas formation, and the frequency is designated as up to four times daily (QID) or as needed for symptoms. The maximum total daily dose for self-medication should not be exceeded.

Age Group Single Dose Range Maximum Daily Limit (approximate)
Adults and Children ≥ 12 years 40 mg to 180 mg 500 mg to 640 mg
Children (2 to 12 years) 40 mg 480 mg
Infants (under 2 years) 20 mg 240 mg

Preparation and Procedural Rules

Specific actions are required for proper ingestion based on the formulation: Oral Suspensions/Drops must be shaken well prior to administration, and the dose must be measured precisely using the enclosed dropper or measuring device. In contrast, chewable tablets must be chewed thoroughly before being swallowed.

Use is typically short-term and based on the presence of symptoms. Documentation advises against continuous use without medical consultation for periods exceeding 10 to 14 days.

Recent Clinical Evidence

Aerox: Recent Clinical Evidence


Research Scope and Primary Focus

Research explored the drug in relation to inflammatory pathways associated with joint-related conditions. Research has primarily focused on the drug's use in adult patients experiencing chronic joint discomfort. Clinical trials explored whether use of the drug was associated with changes in joint mobility and inflammation. Study designs included both short-term (4-week) and long-term (1-year) randomized, placebo-controlled investigations.

Key Findings in Symptom Management

  • Acute Pain Examination: An analysis of two randomized controlled trials (RCTs), involving 450 participants, examined whether use of the drug was associated with changes in acute pain levels. The studies focused on patient-reported outcomes 24 and 48 hours after the initial dose.

  • Chronic Stiffness: A Phase III trial explored whether use of the drug was associated with changes in chronic stiffness over 12 months. This study used the validated Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score for assessment. Studies evaluated the continuation of treatment.

  • Comparison of Treatments: Comparative studies examined the outcomes of this treatment versus older non-steroidal anti-inflammatory drugs (NSAIDs). These head-to-head trials primarily assessed differences in tolerability and a predefined set of adverse events.

Dosage, Administration, and Patient Group Studies

Studies examined outcomes associated with the standard dosage. Research profiles explored the absorption of the drug in relation to administration timing and food intake. Safety data from studies involving adults over 65 was reviewed. These studies included the monitoring of cardiovascular and gastrointestinal events in this age cohort.

  • Quality of Life: A recent meta-analysis supports that studies examined whether the combined therapy was associated with changes in the quality of life. This analysis utilized data from trials employing validated questionnaires that measured daily function and general well-being.

  • Fibromyalgia Exploration: Some early data indicated that studies examined whether the drug was associated with changes in pain associated with fibromyalgia. This research remains preliminary, and further investigation is ongoing.

Key Studies & References

  1. Efficacy of cardiorespiratory aerobic exercise in rheumatoid arthritis: meta-analysis of randomized controlled trials
  2. What's the latest update on the ongoing clinical trials related to Knee Arthritis? (Includes Phase III WOMAC data and subpopulation analysis)

Frequently Asked Questions (FAQ)

Common questions about Aerox (FAQ)


Q: How quickly does Aerox usually start working for symptomatic relief?

Aerox, which contains Simethicone, is a non-systemic agent, meaning it acts only in the gut and is minimally absorbed into the body. Because it works physically to break up gas bubbles, it is generally reported to work quickly to provide symptomatic relief from gas and bloating. Onset of action may vary among individuals.


Q: Can taking Aerox on an empty stomach increase the risk of side effects like upset stomach?

Official directions advise taking the medication after meals and at bedtime. This timing is designed to maximize its effectiveness by aligning with periods when gas formation is most likely to occur. Official product information does not explicitly state an increased risk of side effects from taking it on an empty stomach, but following the labeled instructions is generally recommended.


Q: Does Aerox interact with any common blood thinners?

Official product labels for Simethicone generally do not list common blood thinners (anticoagulants) as agents with a formal interaction risk. However, it is known to have the potential for physical interference with the absorption of other oral medications. It is generally recommended to inform a healthcare provider about any blood thinners or other oral medicines being taken.


Q: Can older adults safely take Aerox, or do they need special monitoring?

Aerox is widely used across all age groups. Official product information does not impose special age-related restrictions for its use in adults. As with any medication, individuals with existing health conditions should follow their healthcare provider's recommendations.


Q: Does Aerox affect my liver function, and should I be concerned about liver health?

Aerox (Simethicone) is not systemically absorbed into the bloodstream and is not metabolized by the liver. Official safety data indicates that due to minimal absorption, systemic side effects like liver injury are not anticipated.


Q: Can Aerox be taken with daily vitamins or supplements like Vitamin B-complex?

Since Aerox works by physical action in the gastrointestinal tract, there is a possibility it could interfere with the absorption of other oral products, including vitamins or supplements. It is important to inform a healthcare provider about all medicines, vitamins, and supplements being used, as they can determine any potential effects on absorption.


Q: Is it common for doctors to monitor kidney and liver function when prescribing Aerox long-term?

Because Aerox is a non-systemic drug and is minimally absorbed, its use is not typically associated with systemic effects on the kidneys or liver. Therefore, the monitoring of these organ functions is not generally required for the use of Simethicone alone.


Q: Is it true that Aerox can make me feel sleepy or affect my concentration?

Regulatory safety data generally does not list drowsiness, dizziness, or effects on concentration as common side effects of this medication. This aligns with its physical mechanism of action, which involves minimal absorption into the bloodstream.


Q: Is there a higher risk of side effects if I take Aerox for a long period of time?

Aerox is primarily used on an as-needed basis to relieve symptoms of gas and bloating. For acute issues, short-term use is typical. Continuous use for periods longer than recommended on the label should be discussed with a healthcare provider to determine the cause of the ongoing symptoms.


Q: Are there any precautions for taking Aerox if I have asthma?

The most serious safety event documented is a rare hypersensitivity reaction (a severe allergic reaction), which may include symptoms such as respiratory difficulty. Individuals with a known allergy to Simethicone or any of the ingredients should not use the product.


Q: Is it better to take the tablet whole, or can I crush or chew Aerox?

The method of administration depends on the formulation. Chewable tablets must be chewed thoroughly before being swallowed. Other forms, like capsules, should be swallowed whole as directed by the instructions on the package.


Q: Are there any known food interactions with Aerox that reduce its effectiveness?

Official government drug labels for the active ingredient do not list specific restrictions or cautions concerning concurrent use with food. In fact, the product is often recommended to be taken after meals.


Q: Is Aerox commonly prescribed for conditions like rheumatoid arthritis or ankylosing spondylitis?

No, Aerox is classified as an antiflatulent (anti-gas agent) and is approved for the relief of symptoms related to excessive gas, bloating, and abdominal discomfort. It is not indicated for the treatment of inflammatory joint conditions like rheumatoid arthritis.


Q: Can Aerox cause fluid retention or swelling in the hands or feet?

Swelling (oedema) of the face or tongue has been reported in post-marketing data as a possible sign of a rare, serious allergic reaction (hypersensitivity). It is not listed as a common side effect such as general fluid retention.


Q: Is there a link between taking Aerox and experiencing abdominal pain?

Aerox is actually indicated for the relief of abdominal discomfort caused by gas and bloating. While side effects like loose stools or nausea may occur, it is intended to resolve gas-related pain, not cause it.


Q: Does taking Aerox affect the results of any common lab tests?

Yes, regulatory warnings note that the product is known to interfere with certain diagnostic procedures. Specifically, it can cause false-negative results in the Gastric Guaiac Test, which is used to check for internal bleeding.


Q: Can Aerox be used for menstrual cramps or other short-term inflammatory pain?

Aerox is an antiflatulent approved only for symptoms related to excessive gas and bloating. It is not indicated for the treatment of short-term pain or inflammation from menstrual cramps or other similar conditions.


Q: Does Aerox lose its effectiveness over time if taken daily?

Since Aerox works via a temporary physical action (breaking up gas bubbles) rather than a pharmacological one, there is no evidence in regulatory data to suggest the development of tolerance or dependency. It should remain effective as long as there is gas to treat.


Q: What are the guidelines for taking Aerox if I have a pre-existing heart condition?

Because the product is not systemically absorbed into the bloodstream, systemic side effects that affect the heart are not expected. As with any persistent or severe symptoms, such as chest pain or abdominal tenderness, it is recommended to seek guidance from a healthcare professional.


Q: Is it normal to have a loss of appetite while taking Aerox?

Official safety data for Simethicone does not list loss of appetite as an officially documented common, uncommon, or rare adverse reaction.


Q: Does the time of day I take Aerox matter for its effectiveness?

The official label advises taking the product after meals and at bedtime. This timing is directed to ensure the medication is present in the digestive system during the common periods of gas formation, maximizing its effectiveness for symptom relief.


Q: How does Aerox work differently than opioid pain relievers?

Aerox is a non-systemic antiflatulent that works via a purely physical mechanism in the gastrointestinal tract to break up gas. Opioid pain relievers, in contrast, are systemic drugs that act on the central nervous system to block pain signals.


Q: Does Aerox interact with medications for diabetes or blood sugar control?

Due to its minimal systemic absorption, the product is not expected to cause systemic side effects like changes in blood sugar. While formal interactions are generally not listed, it is recommended to ensure your healthcare provider is aware of all your current medications.


Q: If I miss a dose of Aerox, is it safe to take it as soon as I remember?

Since Aerox is generally taken as needed for symptoms, if a regular schedule is followed, official guidance typically advises taking the missed dose as soon as remembered, unless it is close to the time for the next dose.


Q: Can Aerox affect sleep quality or cause insomnia?

The product is often recommended to be taken at bedtime to help relieve nocturnal gas and bloating. This suggests that it does not typically cause insomnia or negatively affect sleep quality.

How should Aerox be stored and disposed of?

How to Store and Dispose of Aerox (Simethicone)

Aerox must be stored according to official regulatory specifications to maintain product quality.


Storage and Handling

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Protect from excessive heat and moisture. The liquid suspension must be protected from freezing.
Container Keep the medication in the original container and ensure the cap is tightly closed.
Child Safety Store the product out of the reach and sight of children.

Disposal Requirements

Unused or expired Aerox should be discarded following local regulations. The preferred method is using a medicine take-back program. If this is unavailable, the medicine should be mixed with an undesirable substance and placed in a sealed bag before being put in the household trash. Do not flush the product down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aerox found in:

A-Z Index: